Liposomal Daunorubicin in Treating Patients With Metastatic Breast Cancer
NCT00004207
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
liposomal daunorubicin citrate
Sponsor
University of Leicester